Skip to content
INCYTE CORP (INCY) Stock Price, Key Stats & Insider Trading
Home / Companies / INCY INC
INCYTE CORP (INCY) S&P 500 XNAS SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Net insider selling (90d)
Latest INCY Insider Trades Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
Headquarters WILMINGTON, DE
Employees 2,844
Listed 1993
Exchange XNAS https://www.incyte.com SEC filings for INCY on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 21 132,139 $15.67M Grant or award 50 742,620 Option exercise 36 101,226
INCY Insider Transactions (Form 4) 66 133 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Jan 16, 2026 SS Steven H. Stein - Officer Grant or award Employee Stock Option (right to buy) 19,932
Recent INCY Form 8-K Filings 5
Recent INCY Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 PABLO CAGNONI Officer 10,801 $1.36M View on EDGAR Aug 12, 2026 PABLO CAGNONI Officer
INCY Insider Trading - FAQ
What is the latest insider trade for INCY? INCYTE CORP (INCY) had 39 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for INCY runs to 133 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying INCY stock? No insider purchases of INCY were filed in the last 90 days.
How many insiders are selling INCY stock? 21 insider sales of INCY were filed in the last 90 days, totaling $15.67M.
Where can I see INCY SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks INCY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow INCY insider buys? Create a free InsiderAlpha account and press Watch on this page to add INCY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track INCY insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $25.21B
P/E ratio 46.90
Dividend yield -
Average volume 1.85M
52 week high $132.60
52 week low $81.09
Today's high $127.74
Today's low $123.08
Open $127.74
Volume 1.22M
Previous close $127.74
Shares outstanding 202.70M Market cap
$25.21B
2,844 employees
INCY Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 21 sales totaling $15.67M.
Most-Active INCY Insiders - Last 90 Days 10 Tax withholding / forfeiture 15 86,431
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jan 16, 2026 MI Mohamed Khairie Issa - Officer Grant or award Employee Stock Option (right to buy) 14,237 $0.00 -
Jan 16, 2026 MT Matteo Trotta - Officer Grant or award Employee Stock Option (right to buy) 8,542 $0.00 -
Dec 1, 2025 SS Steven H. Stein - Officer Open-market sale Common Stock 2,559 $102.96 $263K
Dec 1, 2025 SS Steven H. Stein - Officer Tax withholding / forfeiture Common Stock 17,093 $102.04 $1.74M
Dec 2, 2025 SS Steven H. Stein - Officer Open-market sale Common Stock 20,105 $102.51 $2.06M
Dec 1, 2025 RH Richard A. Hoffman - Officer Grant or award Employee Stock Option (right to buy) 43,301 $0.00 -
Nov 21, 2025 TT Thomas Tray - Officer Open-market sale Common Stock 169 $102.00 $17K
Nov 24, 2025 TT Thomas Tray - Officer Open-market sale Common Stock 600 $103.00 $62K
Nov 17, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 278 $104.36 $29K
Nov 17, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 278 $0.00 -
Nov 17, 2025 SD Sheila A. Denton - Officer Option exercise Common Stock 278 $64.25 $18K
Nov 10, 2025 HH Herve Hoppenot - Director Open-market sale Common Stock 187,500 $105.46 $19.77M
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Non-Qualified Stock Option (right to buy) 2,995 $0.00 -
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Incentive Stock Option (right to buy) 1,044 $0.00 -
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Common Stock 1,194 $83.83 $100K
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Common Stock 2,995 $95.76 $287K
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Common Stock 1,044 $95.76 $100K
Nov 5, 2025 SS Steven H. Stein - Officer Open-market sale Common Stock 5,233 $102.20 $535K
Nov 5, 2025 SS Steven H. Stein - Officer Option exercise Non-Qualified Stock Option (right to buy) 1,194 $0.00 -
Nov 4, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 598 $101.36 $61K
Nov 4, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 598 $0.00 -
Nov 3, 2025 LH Lee Heeson - Officer Open-market sale Common Stock 3,074 $94.02 $289K
Oct 15, 2025 SD Sheila A. Denton - Officer Option exercise Common Stock 277 $64.25 $18K
Oct 15, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 277 $85.13 $24K
Oct 15, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 277 $0.00 -
Oct 2, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 599 $87.65 $53K
Oct 2, 2025 SD Sheila A. Denton - Officer Tax withholding / forfeiture Common Stock 3,130 $86.28 $270K
Oct 3, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 3,501 $85.54 $299K
Oct 2, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 599 $0.00 -
Oct 1, 2025 LH Lee Heeson - Officer Tax withholding / forfeiture Common Stock 463 $86.70 $40K
Oct 1, 2025 PM Patrick A. Mayes - Officer Tax withholding / forfeiture Common Stock 1,569 $86.70 $136K
Sep 30, 2025 PC Paul J. Clancy - Director Grant or award Common Stock 285 $84.81 $24K
Sep 30, 2025 EH Edmund Harrigan - Director Grant or award Common Stock 289 $84.81 $25K
Sep 22, 2025 DG David H. Gardner - Officer Grant or award Performance Shares 23,573 $0.00 -
Sep 22, 2025 DG David H. Gardner - Officer Grant or award Employee Stock Option (right to buy) 42,899 $0.00 -
Sep 16, 2025 SD Sheila A. Denton - Officer Option exercise Common Stock 278 $64.25 $18K
Sep 16, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 278 $83.15 $23K
Sep 16, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 278 $0.00 -
Sep 2, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 598 $84.97 $51K
Sep 2, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 598 $0.00 -
Aug 25, 2025 RB Ramitpal K. Basi - Officer Grant or award Performance Shares 16,265 $0.00 -
Aug 25, 2025 RB Ramitpal K. Basi - Officer Grant or award Employee Stock Option (right to buy) 29,230 $0.00 -
Aug 15, 2025 SD Sheila A. Denton - Officer Option exercise Common Stock 277 $64.25 $18K
Aug 15, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 277 $86.81 $24K
Aug 15, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 277 $0.00 -
Aug 4, 2025 SD Sheila A. Denton - Officer Open-market sale Common Stock 598 $75.77 $45K
Aug 4, 2025 SD Sheila A. Denton - Officer Option exercise Employee Stock Option (right to buy) 598 $0.00 -
Jul 21, 2025 SS Steven H. Stein - Officer Open-market sale Common Stock 3,706 $67.94 $252K
Jul 16, 2025 VI Vijay K. Iyengar - Officer Open-market sale Common Stock 983 $68.36 $67K
$NRC
NRC HEALTH
Pablo J. Cagnoni - OfficerOpen-market sale$1.36M
